By Dr. Paul HERZUAHIn this highly globalised world, competition from foreigners within respective national economies are not only inevitable, but they can also be very beneficial for the host economy.

FDA formally announced the end of the tirzepatide shortage in a Declaratory Order issued to Eli Lilly & Co. (“Lilly”). Lilly ...

Bernstein analysts maintained their positive stance on Eli Lilly (NYSE:LLY) shares, reiterating an Outperform rating and a price target of $1,100.00. The endorsement comes amidst a competitive ...